JHS Svendgaard Retail Ventures Limited (NSE:RETAIL)

Lumos Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Aug 7, 2025	Mar 31, 2025	Mar 31, 2024
Market Capitalization	315	246	-
Enterprise Value	310	317	-
Last Close Price	38.01	34.05	-
PE Ratio	268.13	209.76	-
PS Ratio	1.95	1.53	-
PB Ratio	1.81	1.42	-
P/TBV Ratio	1.81	1.42	-
EV/Sales Ratio	1.92	1.96	-
EV/EBITDA Ratio	8.14	8.33	-
EV/EBIT Ratio	30.31	31.02	-
Debt / Equity Ratio	0.44	0.44	0.11
Debt / EBITDA Ratio	2.00	2.00	1.05
Debt / FCF Ratio	-	-	2.21
Asset Turnover	0.93	0.93	-
Inventory Turnover	8.11	8.11	-
Quick Ratio	1.46	1.46	2.40
Current Ratio	2.02	2.02	3.95
Return on Equity (ROE)	0.99%	0.99%	-
Return on Assets (ROA)	3.70%	3.70%	-
Return on Capital (ROIC)	3.98%	3.98%	-
Return on Capital Employed (ROCE)	5.10%	5.10%	8.60%
Earnings Yield	0.37%	0.48%	-
FCF Yield	-9.21%	-11.77%	-
Buyback Yield / Dilution	0.08%	0.08%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.